1H magnetic resonance spectroscopy in preclinical Huntington disease
Authors:
- 1 September 2007
- journal article
- Published by Elsevier in Brain Research
- Vol. 1168, 67-71
Abstract
No abstract availableKeywords
Funding Information
- Prinses Beatrix Spierfonds
This publication has 15 references indexed in Scilit:
- Decreased frontal choline and neuropsychological performance in preclinical Huntington diseaseNeurology, 2007
- Differential aging of the brain: Patterns, cognitive correlates and modifiersNeuroscience & Biobehavioral Reviews, 2006
- Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington's diseaseBrain Research, 2004
- Onset and rate of striatal atrophy in preclinical Huntington diseaseNeurology, 2004
- Clinical markers of early disease in persons near onset of Huntington’s diseaseNeurology, 2001
- Clinical correlation of striatal 1H MRS changes in Huntington’s diseaseNeurology, 1999
- Experimental Therapeutics of Neurodegenerative Disorders: Unmet NeedsScience, 1998
- 1 H NMR spectroscopy studies of Huntington's diseaseNeurology, 1998
- CAG repeat number governs the development rate of pathology in Huntington's diseaseAnnals of Neurology, 1997
- Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's diseaseBrain, 1996